This inventor holds 2 USPTO granted patents. Top assignees: Celltech R&d Limited, Ucb S.a.. Active years: 2009-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2011
Title: Innovations by Matthew P Fitzgibbon
Introduction
Matthew P Fitzgibbon is an accomplished inventor based in Bellevue, WA. He holds two patents that focus on advancements in the diagnosis and treatment of psoriasis. His work has significantly contributed to the field of medical research, particularly in the development of polypeptide antibodies.
Latest Patents
Fitzgibbon's latest patents include "19.5 polypeptide antibodies useful for diagnosing or treating psoriasis." This invention provides nucleic acid molecules, polypeptides, antibodies, and methods for the diagnosis and/or treatment of psoriasis. Another notable patent is "Antibodies for diagnosing psoriasis," which also offers nucleic acid molecules, polypeptides, antibodies, and methods for the diagnosis and/or treatment of this condition.
Career Highlights
Throughout his career, Fitzgibbon has worked with prominent companies such as UCB S.A. and Celltech R&D Limited. His experience in these organizations has allowed him to develop innovative solutions in the medical field.
Collaborations
Some of his notable coworkers include Patrick R Charmley and Ryan C Smith. Their collaboration has likely contributed to the success of Fitzgibbon's inventions.
Conclusion
Matthew P Fitzgibbon's contributions to the field of psoriasis treatment through his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the lives of many individuals affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile